Skip to content
value.today

CircuLite Inc

Total raised
$12 M
1 round on record
Latest round
$12 M
Mar 2009
First round on record
Mar 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CircuLite Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2009$12 MNo. 1$10 to $50 million

CircuLite Inc: Raise no. 1, Mar 2009

Investors in this round

9 investors had bought by the notice of Jul 7, 2009: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $45 M offered; $34 M still to sell
Smallest investment taken
$24,834
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Southworth · Executive Officer, Director
  • Peter Pfreundschuh · Executive Officer
  • Tricia Wright · Executive Officer
  • Alexia Perouse · Director
  • Avi Molcho · Director
  • Jeffrey Barnes · Director
  • Lee Wrubel, M.D. · Director
  • Martien van Osch · Director
  • Richard Geoffrion · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Lazard Freres & Co. LLC (CRD 2528) · New York, NySold in no state named

Remarks in the notice

  • On fees: “The fee will not be payable unless additional shares are issued in the financing.”

Signed by Peter Pfreundschuh, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 7, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CircuLite Inc chose not to state its revenue in its newest notice of a funding round (Jul 2009).

    SEC Form D · Jul 2009

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2009

That is all the official record says: CircuLite Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CircuLite Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CircuLite Inc
NameRoleNamed in
Paul SouthworthExecutive officerJul 2009
Peter PfreundschuhExecutive officerJul 2009
Tricia WrightExecutive officerJul 2009
Alexia PerouseDirectorJul 2009
Avi MolchoDirectorJul 2009
Jeffrey BarnesDirectorJul 2009
Lee Wrubel, M.D.DirectorJul 2009
Martien van OschDirectorJul 2009
Paul SouthworthDirectorJul 2009
Richard GeoffrionDirectorJul 2009